| Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316) |
|---|
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/15/2001 | CN1308541A Extracts of zanthoxylum bungeanum, pharmaceuti-cal and cosmetic formulations containing them |
| 08/15/2001 | CN1308492A Hypericin and i(hypericum) extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics |
| 08/14/2001 | US6274621 Ginkgolides for inhibition of membrane expression of benzodiazepine receptors |
| 08/14/2001 | US6274567 Orally administering high amylose starch |
| 08/14/2001 | US6274548 Pectic substance as a growth factor stabilizer |
| 08/14/2001 | US6274177 Preparing crude liquid from rhizomes of ginger by extraction with organic solvent or by distillation with steam; introducing to reverse phase chromatography column, and eluting column with water; removing eluents; extraction |
| 08/14/2001 | US6274176 For therapy of arthritis and gout in mammals |
| 08/14/2001 | US6274154 Aloe Vera glove and manufacturing method |
| 08/14/2001 | US6274146 Biologically active phytogenous proteoglycan and a method of making thereof |
| 08/14/2001 | US6274123 For effecting in skin, hair, eyelashes or nails of a human, an effect which can be emollient, softening, insulating, repair, hydration, soothing, emulsifying, nutrient, regenerative, anti-free radical, local anti-inflammatory functions |
| 08/14/2001 | CA2014390C Therapeutical compositions for the treatment or the prevention of snoring |
| 08/09/2001 | WO2001056959A1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 08/09/2001 | WO2001056589A2 Physiologically active compositions of basidiomycotina and araliaceae extracts |
| 08/09/2001 | WO2001056588A1 Phytotherapeutic composition for eliminating heavy metals |
| 08/09/2001 | WO2001056586A1 Method for the isolation of caffeine-free catechins from green tea |
| 08/09/2001 | WO2001056585A1 Cognitive enhancer comprising ginseng extract |
| 08/09/2001 | WO2001056584A1 Method for preparing plant extracts, plant extracts obtained by said method and uses thereof |
| 08/09/2001 | WO2001056583A1 Medicine containing anemonin as effective component for treating aseptic inflammation |
| 08/09/2001 | WO2001056580A1 Compositions of polygonum odoratum for prevention and treatment of disease |
| 08/09/2001 | WO2001056579A1 Methods for treating alzheimer's disease |
| 08/09/2001 | WO2001056541A1 Cosmetic preparations containing waltheria indica extracts |
| 08/09/2001 | WO2001056406A1 Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 08/09/2001 | WO2000015202A3 Topical application products |
| 08/09/2001 | US20010012840 Topical transdermal treatments |
| 08/09/2001 | US20010012534 Comprising soluble and insoluble fiber, low fat, carbohydrates, carotenoids, vitamins, minerals and trace elements; chewable granules, powder, or wafers |
| 08/09/2001 | US20010012525 Dehydrating fruit juices; free-flowing nutrient |
| 08/09/2001 | US20010012523 Plant extracts for the treatment of increased bone resorption |
| 08/09/2001 | CA2762121A1 The use of bicyclo [3.2.1]octan or kaurene for the treatment of non-insulin dependent diabetes mellitus, hypertension and metabolic syndrome |
| 08/09/2001 | CA2399123A1 Medicament for treating aseptic inflammations containing anemonin as effective component |
| 08/08/2001 | EP1121927A2 A composition causing different skin sensations |
| 08/08/2001 | EP1121926A1 Cosmetic preparations containing Waltheria indica extracts |
| 08/08/2001 | EP1121139A1 Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid |
| 08/08/2001 | EP1121138A2 Compositions for the treatment of atherosclerosis and related conditions |
| 08/08/2001 | EP1121106A1 Treatment of dyspepsia |
| 08/08/2001 | EP1037647B1 Medicinal plant dry extracts |
| 08/08/2001 | EP0815112B1 Process for isolating galanthamine |
| 08/08/2001 | EP0759740B1 Use of laminarin and oligosaccharides derived therefrom in cosmetics and for preparing a skin treatment drug |
| 08/08/2001 | CN1307583A Method for preparing aloin by extraction |
| 08/08/2001 | CN1307479A Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression |
| 08/08/2001 | CN1307473A Triterpene compositions and methods for use thereof |
| 08/08/2001 | CN1307446A Fossorial rodent control compositions and method |
| 08/08/2001 | CN1306818A Medicine for treating abacterial inflammation and its extraction method |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271246 Antidandruff composition with acidic component having alpha-or beta-hydroxy acid or tannic acid which exfoliates scalp; vitamin a component inhibits overproducing stratum corneum; antigrowth agent inhibits fungus, yeast, and bacteria |
| 08/07/2001 | US6271215 For humans or animals |
| 08/07/2001 | US6271214 Process for the preparation of immunomodulatory polysaccharides from aloe |
| 08/07/2001 | US6271174 Method of and products for promoting improved growth of plants and more water-efficient growing soilor other media and the like with antzeolite crystals treated with preferably water-based plant-derived nutrient extractions and the like |
| 08/07/2001 | US6270811 Inactive culture of bacteria of the genus bifidobacterium compatible in cosmetics or pharmacy, in a mixture with an essential oil, and an organic acid. |
| 08/07/2001 | US6270803 Granulated garlic particles which have been microencapsulated by direct coating with an enteric coating and at least one pharmaceutically acceptable diluent, adjuvant or excipient therefor. |
| 08/07/2001 | US6270774 To increase levels of high density lipoprotein (hdl) and calcium ions, and decrease levels of free radicals and glucose in human blood plasma. |
| 08/07/2001 | US6270752 Based on essential oils obtainable through alcoholic distillation of plants which contain the essential oils, combined with salicylic acid and with fatty acids having 10 to 40 carbon atoms. |
| 08/02/2001 | WO2001054659A2 Slimming cosmetic composition comprising a plant extract containing a plant natriuretic peptide (pnp) |
| 08/02/2001 | WO2001054516A1 Method for inhibiting a tumor |
| 08/02/2001 | US20010011100 Use of an angiogenesis inhibitor as a lead compound in drug development |
| 08/02/2001 | US20010011083 Pain reliever and method of use |
| 08/02/2001 | US20010011081 Pharmaceutical composition comprising L- carnitine or alkanoyl L-carnitine for the prevention and treatment of diseases brought about by lipid metabolism disorders |
| 08/02/2001 | US20010010813 Compositions comprising ratite oil or active fractions thereof and methods of using these composition as insect repellents |
| 08/02/2001 | DE10004349A1 Agent for inhibiting unwanted cell growth is obtained from lysed cells of organisms comprising terminator gene products |
| 08/02/2001 | CA2398631A1 Slimming cosmetic composition comprising as an ative agent a plant extract containing a plant natriuretic peptide (pnp) |
| 08/01/2001 | EP1120118A1 Preventives/remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 08/01/2001 | EP1120108A1 Skin preparations for external use |
| 08/01/2001 | EP1120107A1 Nutritional supplement based on blackcurrant seed oil |
| 08/01/2001 | EP1119363A2 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 08/01/2001 | EP0975350B1 Use of an extract of alchemilla vulgaris |
| 08/01/2001 | EP0777489B1 Low molecular yeast active substance extract and process for preparing the same |
| 08/01/2001 | CN1306434A Compsn. for prevention and/or treatment of osteoporosis and alterations due to menopause syndrome |
| 08/01/2001 | CN1305805A Compsns. contg. ascorbic acid and pectin |
| 07/31/2001 | US6268399 Salal extracts having antimicrobial properties |
| 07/31/2001 | US6268395 Phorbol derivatives having antivirus activity |
| 07/31/2001 | US6268011 Mixture of soybean protein and soybean fiber |
| 07/31/2001 | US6267996 Antimicrobial or preservative comprising hydrophilic extract of krameria obtained by extracting roots, bark or leaves with protic solvent or acetone and lipophilic extract of mesua ferrea obtained by extracting flowers with aprotic solvent |
| 07/31/2001 | US6267995 Isolated composition obtained by extracting lepidium meyenii roots with aqueous solvent, substantially free of cellulose, comprising benzyl isothiocyanate, lepidium sterol component, lepidium fatty acid component, and macamide component |
| 07/31/2001 | US6267994 Use of extract of cimicifuga racemosa |
| 07/31/2001 | US6267993 Powder having in vitro reverse transcriptase inhibiting activity, obtained by immediately subjecting collected plant starting material to quick heating to deactivate enzymes, drying at low temperature, milling |
| 07/31/2001 | US6267992 Administering metabolite of salviae miltiorrhizac radix herb to diabetic individual to treat diabetic nephropathy |
| 07/31/2001 | US6267985 Clear oil-containing pharmaceutical compositions |
| 07/31/2001 | US6267963 Plant sterol-emulsifier complexes |
| 07/31/2001 | US6267962 Compositions and methods of treatment using peat derivatives |
| 07/31/2001 | US6267946 Cultivating epstein-barr virus(ebv) genome-carrying cells in presence of tumor-promoting chemical or tumor-inducing chemical; treating ebv genome-carrying cells with synthetic colorant to reduce early antigen induction |
| 07/26/2001 | WO2001053441A2 Processes for obtaining (-)-guaiol and the use thereof |
| 07/26/2001 | WO2001052886A1 Prime-boost vaccination strategy |
| 07/26/2001 | WO2001052873A1 VEGETABLE OIL FOR PREPARING A COMPOSITION INHIBITING 5α- REDUCTASE ACTIVITY |
| 07/26/2001 | WO2001052872A2 Method for producing ointment for treatment of burns 'healthyderm' and application of same |
| 07/26/2001 | WO2001052870A1 Treatment of congestive heart failure by pretreated autologous blood |
| 07/26/2001 | WO2001052856A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 07/26/2001 | WO2001052840A1 Use of isoflavones and/or african plum extracts for preparing a composition designed to inhibit 5$g(a)-reductase activity, in pharmacology particularly in dermatology, in cosmetics and as food additive |
| 07/26/2001 | WO2001052809A1 Cosmetic and/or pharmaceutical preparations containing an active quantity of an arrabidaea chica extract |
| 07/26/2001 | WO2001052648A1 Improvements to artificial blood fluids and microflow drag reducing factors for enhanced blood circulation |
| 07/26/2001 | WO2001021137A8 Extracts of orange peel for prevention and treatment of cancer |
| 07/26/2001 | US20010009903 Roasting process using far infrared radiation, microorganism fermentation to produce peroxide lipid thereby improving antitumor activity |
| 07/26/2001 | US20010009682 A stable disinfectant concentrate comprising a mono or dialdehyde containing 2 to 11 carbon atoms, a glycol or polyol containing 2-10 carbon atoms and a lithium based buffer soluble in concentrate for controlling pH 6 or above |
| 07/26/2001 | US20010009681 Methods of use for dietary compositions comprising lactoferrin and colostrum |
| 07/26/2001 | DE10100779A1 Formulierung Formulation |
| 07/26/2001 | DE10037590A1 Natural plant disinfectant and its preparation |
| 07/26/2001 | CA2402831A1 Prime-boost vaccination strategy |
| 07/25/2001 | EP1117418A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117417A1 Pharmaceutically active plant preparation for the treatment of migraine |
| 07/25/2001 | EP1117416A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117415A1 Use of extracts from aristolochia in the treatment of aids |